Underwritten Public Offering (Details) - USD ($) |
1 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Aug. 31, 2020 |
Aug. 31, 2020 |
Sep. 30, 2020 |
Sep. 30, 2019 |
|
Underwritten Public Offering (Textual) | ||||
Common stock warrants to purchase | 10,608,750 | |||
Sale of common stock net | 12,300,000 | |||
Proceeds from the At-the-Market Offering, net | $ 13,655,531 | $ 4,308,352 | ||
Professional fees | $ 1,368,919 | $ 214,456 | ||
Warrants exercise price | $ 1.44 | |||
Exercisable term | 5 years | 5 years | ||
Underwritten Public Offering [Member] | ||||
Underwritten Public Offering (Textual) | ||||
Common stock warrants to purchase | 10,608,750 | |||
Sale of common stock net | 12,300,000 | |||
Proceeds from the At-the-Market Offering, net | $ 13,655,531 | |||
Professional fees | $ 1,368,919 | |||
Warrants exercise price | $ 1.44 | |||
Exercisable term | 5 years | 5 years |
X | ||||||||||
- Definition Common stock warrants to purchase. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Underwritten Public Offering. No definition available.
|
X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Details
|